Cargando…
Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071115/ https://www.ncbi.nlm.nih.gov/pubmed/36453110 http://dx.doi.org/10.3324/haematol.2022.282014 |
| _version_ | 1785019133928144896 |
|---|---|
| author | Suleman, Adam Liu, Jiajia Hicks, Lisa K. Drori, Adi Klil Crump, Michael Kridel, Robert Prica, Anca Berinstein, Neil |
| author_facet | Suleman, Adam Liu, Jiajia Hicks, Lisa K. Drori, Adi Klil Crump, Michael Kridel, Robert Prica, Anca Berinstein, Neil |
| author_sort | Suleman, Adam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10071115 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100711152023-04-05 Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience Suleman, Adam Liu, Jiajia Hicks, Lisa K. Drori, Adi Klil Crump, Michael Kridel, Robert Prica, Anca Berinstein, Neil Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-12-01 /pmc/articles/PMC10071115/ /pubmed/36453110 http://dx.doi.org/10.3324/haematol.2022.282014 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Suleman, Adam Liu, Jiajia Hicks, Lisa K. Drori, Adi Klil Crump, Michael Kridel, Robert Prica, Anca Berinstein, Neil Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience |
| title | Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience |
| title_full | Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience |
| title_fullStr | Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience |
| title_full_unstemmed | Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience |
| title_short | Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience |
| title_sort | methotrexate, cytarabine, thiotepa and rituximab (matrix) chemoimmunotherapy for primary central nervous system lymphoma: a toronto experience |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071115/ https://www.ncbi.nlm.nih.gov/pubmed/36453110 http://dx.doi.org/10.3324/haematol.2022.282014 |
| work_keys_str_mv | AT sulemanadam methotrexatecytarabinethiotepaandrituximabmatrixchemoimmunotherapyforprimarycentralnervoussystemlymphomaatorontoexperience AT liujiajia methotrexatecytarabinethiotepaandrituximabmatrixchemoimmunotherapyforprimarycentralnervoussystemlymphomaatorontoexperience AT hickslisak methotrexatecytarabinethiotepaandrituximabmatrixchemoimmunotherapyforprimarycentralnervoussystemlymphomaatorontoexperience AT droriadiklil methotrexatecytarabinethiotepaandrituximabmatrixchemoimmunotherapyforprimarycentralnervoussystemlymphomaatorontoexperience AT crumpmichael methotrexatecytarabinethiotepaandrituximabmatrixchemoimmunotherapyforprimarycentralnervoussystemlymphomaatorontoexperience AT kridelrobert methotrexatecytarabinethiotepaandrituximabmatrixchemoimmunotherapyforprimarycentralnervoussystemlymphomaatorontoexperience AT pricaanca methotrexatecytarabinethiotepaandrituximabmatrixchemoimmunotherapyforprimarycentralnervoussystemlymphomaatorontoexperience AT berinsteinneil methotrexatecytarabinethiotepaandrituximabmatrixchemoimmunotherapyforprimarycentralnervoussystemlymphomaatorontoexperience |